MedPath

Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal Hypertension

Not Applicable
Recruiting
Conditions
Liver Cirrhosis
Portal Hypertension
Pain
Interventions
Registration Number
NCT04724148
Lead Sponsor
Hepatopancreatobiliary Surgery Institute of Gansu Province
Brief Summary

Portal hypertension is a common complication of chronic liver disease and is associated with most clinical consequences of cirrhosis. The most reliable method for assessing portal hypertension is the measurement of the hepatic venous pressure gradient (HVPG). The HVPG is the gold-standard methods for assessing clinically significant portal hypertension and becoming increasingly used clinically. It is useful in the differential diagnosis of portal hypertension and provides a prognostic index in cirrhotic patients. Many patients are painful and reluctant to undergo serial HVPG measurements. But interventionists are reluctant to use analgesics because they always pay more attention to the accuracy of HVPG measurements.Although Adam F. et al concluded that low-dose midazolam sedation is an option for patients undergoing serial hepatic venous pressure measurements (Hepatology 1999), the effects of using opioid analgesics alone on hepatic venous pressure measurements have not yet been defined. The objective of this study was to evaluate the effects of fentanyl on the HVPG.

Detailed Description

Portal hypertension is a common complication of chronic liver disease and is associated with most clinical consequences of cirrhosis. The most reliable method for assessing portal hypertension is the measurement of the hepatic venous pressure gradient (HVPG). The HVPG is the gold-standard methods for assessing clinically significant portal hypertension and becoming increasingly used clinically. It is useful in the differential diagnosis of portal hypertension and provides a prognostic index in cirrhotic patients. Many patients are painful and reluctant to undergo serial HVPG measurements. But interventionists are reluctant to use analgesics because they always pay more attention to the accuracy of HVPG measurements. May be since it is difficult to monitor HVPG for anesthesiologist during liver surgery, there are very few and controversial studies on the effects of sedation and analgesics on HVPG. M. Susan Mandell et al concluded that desflurane alters HVPG measurements, whereas propofol did not change it (Anesth Analg 2003). However, Enric Reverter et al considered that deep sedation with propofol and remifentanil adds substantial variability and uncertainty to HVPG measurements (Liver International 2013). Although Adam F. et al concluded that low-dose midazolam sedation is an option for patients undergoing serial hepatic venous pressure measurements (Hepatology 1999), the effects of using opioid analgesics alone on hepatic venous pressure measurements have not yet been defined. The objective of this study was to evaluate the effects of fentanyl on the HVPG measurements.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
4
Inclusion Criteria
  • Patients with cirrhosis and portal hypertension undergoing elective TIPS placement
  • ASAⅠ~Ⅲ
Exclusion Criteria
  • Patients with portal vein thrombosis and vein-to-vein communications
  • Refusal of consent
  • Presence of allergy to fentanyl

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Injecting 1~2mg/kg fentanyl intravenously.Fentanyl1. Measuring HVPG after the preparation of TIPS in patients with portal hypertension; 2. Measuring HVPG again 5 minutes later after injecting 1\~2mg/kg fentanyl intravenously.
Primary Outcome Measures
NameTimeMethod
Accuracy of HVPG1~2 hours

To assess whether fentanyl would affect the accuracy of hepatic venous pressure gradient measurements in patients with cirrhosis.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The First Hospital of Lanzhou University

🇨🇳

Lanzhou, Gansu, China

© Copyright 2025. All Rights Reserved by MedPath